Arenobufagin: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
Line 1: Line 1:
'''Arenobufagin''' is a [[cardiac glycoside]], a type of compound that has a specific effect on the heart. It is derived from the venom of the [[toad]] species ''[[Bufo arenarum]]'', commonly known as the Argentine common toad. Arenobufagin has been studied for its potential use in [[cancer treatment]] due to its ability to inhibit the growth of cancer cells.
{{short description|Political party in New Zealand advocating for cannabis law reform}}
{{Use dmy dates|date=October 2023}}


==Chemical Structure==
The '''Aotearoa Legalise Cannabis Party''' (ALCP) is a political party in [[New Zealand]] that advocates for the legalisation of [[cannabis]]. The party was founded in 1996 and has participated in several general elections, although it has not won any seats in the [[New Zealand Parliament]].
Arenobufagin is a steroid-like compound, which is characteristic of cardiac glycosides. It has a complex chemical structure that includes a steroid nucleus and a sugar moiety. The steroid nucleus is responsible for the biological activity of the compound, while the sugar moiety affects its solubility and bioavailability.


==Mechanism of Action==
==History==
The primary mechanism of action of arenobufagin is the inhibition of the [[sodium-potassium pump]], also known as the Na+/K+-ATPase. This enzyme is responsible for maintaining the balance of sodium and potassium ions in cells. By inhibiting this enzyme, arenobufagin disrupts the ion balance, leading to an increase in intracellular calcium levels. This increase in calcium levels can trigger cell death, or apoptosis, in cancer cells.
The Aotearoa Legalise Cannabis Party was established in response to growing public support for cannabis law reform in New Zealand. The party's primary goal is to change the legal status of cannabis, allowing for its regulated use for medicinal, recreational, and industrial purposes.


==Potential Therapeutic Uses==
Since its inception, the ALCP has campaigned in every general election, promoting policies that focus on the benefits of cannabis legalisation, including potential economic gains, health benefits, and the reduction of crime associated with the illegal cannabis trade.
Arenobufagin has been studied for its potential use in the treatment of various types of cancer, including [[breast cancer]], [[lung cancer]], and [[leukemia]]. In vitro studies have shown that arenobufagin can inhibit the growth of these cancer cells and induce apoptosis. However, further research is needed to determine the safety and efficacy of arenobufagin in humans.


==Toxicity==
==Policies==
Like other cardiac glycosides, arenobufagin can be toxic at high doses. Symptoms of toxicity can include nausea, vomiting, abdominal pain, and irregular heartbeat. In severe cases, cardiac glycoside toxicity can lead to life-threatening heart rhythm abnormalities.
The ALCP's policies are centered around the legalisation and regulation of cannabis. Key policy points include:


==See Also==
* '''Medicinal Cannabis''': Advocating for the legal use of cannabis for medicinal purposes, allowing patients to access cannabis-based treatments with a prescription.
* [[Cardiac glycoside]]
* '''Recreational Use''': Supporting the legalisation of cannabis for recreational use, with regulations similar to those for alcohol and tobacco.
* [[Bufo arenarum]]
* '''Industrial Hemp''': Promoting the cultivation and use of industrial hemp for a variety of products, including textiles, food, and biofuels.
* [[Cancer treatment]]
* '''Education and Research''': Encouraging research into the benefits and risks of cannabis use and providing public education on responsible consumption.


[[Category:Cardiac glycosides]]
==Election Results==
[[Category:Toxins]]
The ALCP has participated in every general election since 1996. While the party has not secured any seats in Parliament, it has consistently raised awareness about cannabis law reform and influenced public discourse on the issue.
[[Category:Potential medication]]
 
{{Chemical compound-stub}}
===General Elections===
{{Medicine-stub}}
The party's best performance was in the 1996 general election, where it received 1.66% of the party vote. In subsequent elections, the party's share of the vote has varied, reflecting changing public attitudes towards cannabis legalisation.
 
==Impact and Influence==
Despite not winning seats, the ALCP has played a significant role in shaping the conversation around cannabis in New Zealand. The party's advocacy has contributed to increased public support for cannabis law reform, culminating in the 2020 [[Cannabis referendum in New Zealand|cannabis referendum]]. Although the referendum did not pass, it demonstrated significant public interest in the issue.
 
==Related pages==
* [[Cannabis in New Zealand]]
* [[Cannabis law reform]]
* [[New Zealand general election, 1996]]
* [[Cannabis referendum in New Zealand]]
 
==Gallery==
<gallery>
File:AotearoaLegaliseCannabisPartyLogo.png|Logo of the Aotearoa Legalise Cannabis Party
</gallery>
 
[[Category:Political parties in New Zealand]]
[[Category:Cannabis law reform organizations]]
[[Category:Single-issue political parties]]
[[Category:Political parties established in 1996]]

Revision as of 17:36, 11 February 2025

Political party in New Zealand advocating for cannabis law reform



The Aotearoa Legalise Cannabis Party (ALCP) is a political party in New Zealand that advocates for the legalisation of cannabis. The party was founded in 1996 and has participated in several general elections, although it has not won any seats in the New Zealand Parliament.

History

The Aotearoa Legalise Cannabis Party was established in response to growing public support for cannabis law reform in New Zealand. The party's primary goal is to change the legal status of cannabis, allowing for its regulated use for medicinal, recreational, and industrial purposes.

Since its inception, the ALCP has campaigned in every general election, promoting policies that focus on the benefits of cannabis legalisation, including potential economic gains, health benefits, and the reduction of crime associated with the illegal cannabis trade.

Policies

The ALCP's policies are centered around the legalisation and regulation of cannabis. Key policy points include:

  • Medicinal Cannabis: Advocating for the legal use of cannabis for medicinal purposes, allowing patients to access cannabis-based treatments with a prescription.
  • Recreational Use: Supporting the legalisation of cannabis for recreational use, with regulations similar to those for alcohol and tobacco.
  • Industrial Hemp: Promoting the cultivation and use of industrial hemp for a variety of products, including textiles, food, and biofuels.
  • Education and Research: Encouraging research into the benefits and risks of cannabis use and providing public education on responsible consumption.

Election Results

The ALCP has participated in every general election since 1996. While the party has not secured any seats in Parliament, it has consistently raised awareness about cannabis law reform and influenced public discourse on the issue.

General Elections

The party's best performance was in the 1996 general election, where it received 1.66% of the party vote. In subsequent elections, the party's share of the vote has varied, reflecting changing public attitudes towards cannabis legalisation.

Impact and Influence

Despite not winning seats, the ALCP has played a significant role in shaping the conversation around cannabis in New Zealand. The party's advocacy has contributed to increased public support for cannabis law reform, culminating in the 2020 cannabis referendum. Although the referendum did not pass, it demonstrated significant public interest in the issue.

Related pages

Gallery